HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma

被引：0
|
作者：
Zimin Liu
Mingpeng Shi
Xiaoxiao Li
Shanai Song
Ning Liu
Haiwei Du
Junyi Ye
Haiyan Li
Zhou Zhang
Lu Zhang
机构：
[1] The Affiliated Hospital of Qingdao University,Oncology Department
[2] Burning Rock Biotech,Operating Room of Neurosurgery
[3] The Affiliated Hospital of Qingdao University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2021年 / 147卷
关键词：
Copy number; Resectable gastric adenocarcinoma; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1315 / 1324
页数：9
相关论文
共 50 条
  • [41] Coexpression of HER3 as a predictor of survival in HER2-positive breast cancer patients.
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Bago-Horvath, Zsuzanna
    Preusser, Mathias
    Steger, Guenther G.
    Rudas, Margareta
    Birner, Peter
    Zielinski, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Pembrolizumab in HER2-Positive Gastric Cancer
    Janjigian, Yelena Y.
    Kawazoe, Akihito
    Bai, Yuxian
    Xu, Jianming
    Lonardi, Sara
    Metges, Jean Phillipe
    Yanez, Patricio
    Wyrwicz, Lucjan S.
    Shen, Lin
    Ostapenko, Yuriy
    Bilici, Mehmet
    Chung, Hyun Cheol
    Shitara, Kohei
    Qin, Shukui
    Van Cutsem, Eric
    Tabernero, Josep
    Luo, Suxia
    Mahave, Mauricio
    Tang, Yong
    Lowery, Maeve
    Monteiro, Maria M. F.
    Xu, Linzhi
    Shih, Chie-Schin
    Sharan, Kanu P.
    Bhagia, Pooja
    Rha, Sun Young
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (14): : 1360 - 1362
  • [43] Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)
    Seyoung Seo
    Min-Hee Ryu
    Young Soo Park
    Ji Yong Ahn
    Yangsoon Park
    Sook Ryun Park
    Baek-Yeol Ryoo
    Gin Hyug Lee
    Hwoon-Young Jung
    Yoon-Koo Kang
    Gastric Cancer, 2019, 22 : 527 - 535
  • [44] HER2 gene copy number and breast cancer- specific survival
    Biserni, Giovanni B.
    Engstrom, Monica J.
    Bofin, Anna M.
    HISTOPATHOLOGY, 2016, 69 (05) : 871 - 879
  • [45] Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)
    Seo, Seyoung
    Ryu, Min-Hee
    Park, Young Soo
    Ahn, Ji Yong
    Park, Yangsoon
    Park, Sook Ryun
    Ryoo, Baek-Yeol
    Lee, Gin Hyug
    Jung, Hwoon-Young
    Kang, Yoon-Koo
    GASTRIC CANCER, 2019, 22 (03) : 527 - 535
  • [46] Pembrolizumab in HER2-Positive Gastric Cancer
    Janjigian, Yelena Y.
    Kawazoe, Akihito
    Bai, Yuxian
    Xu, Jianming
    Lonardi, Sara
    Metges, Jean Phillipe
    Yanez, Patricio
    Wyrwicz, Lucjan S.
    Shen, Lin
    Ostapenko, Yuriy
    Bilici, Mehmet
    Chung, Hyun Cheol
    Shitara, Kohei
    Qin, Shukui
    Van Cutsem, Eric
    Tabernero, Josep
    Luo, Suxia
    Mahave, Mauricio
    Tang, Yong
    Lowery, Maeve
    Monteiro, Maria M. F.
    Xu, Linzhi
    Shih, Chie-Schin
    Sharan, Kanu P.
    Bhagia, Pooja
    Rha, Sun Young
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [47] Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: Results of GASTric cancer HER2 reassessment study 3 (GASTHER3).
    Seo, Seyoung
    Ryu, Min-Hee
    Ahn, Ji Yong
    Park, Yangsoon
    Park, Sook Ryun
    Ryoo, Baek-Yeol
    Park, Young Soo
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [48] Targeting HER2 in the management of potentially resectable gastric adenocarcinoma: what are oncologists waiting for?
    El Gharib, Khalil
    Kourie, Hampig R.
    FUTURE ONCOLOGY, 2020, 16 (33) : 2683 - 2686
  • [49] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN HER2 NEGATIVE (HER2-) PRIMARY BREAST CANCER (BC)
    McCrea, C.
    Chatzidaki, I
    Drane, E.
    McArthur, E.
    Beaver, S.
    Reason, T.
    Gulati, P.
    VALUE IN HEALTH, 2020, 23 : S425 - S425
  • [50] Tumor-infiltrating lymphocytes but not HER2 copy number or ratio show prognostic value in trastuzumab-treated HER2-positive breast cancer
    Robertson, Stephanie
    Ronnlund, Caroline
    Fredriksson, Irma
    Foukakis, Theodoros
    Hartman, Johan
    CANCER RESEARCH, 2022, 82 (04)
12345